Integrative human pan-cancer analysis of NDC80

Background NDC80 is pivotal in cell division, particularly in regulating the G2/M transition and mitotic progression. Recent studies have demonstrated that NDC80 is significantly overexpressed in multiple solid tumors. Further analysis has suggested that its high expression is significantly associated with an elevated pathological grade, increased metastatic risk, and shortened overall survival in patients with cancer. However, its precise role in pan-cancer development, progression, and prognosis remains unclear. Methods We conducted a multi-omics analysis of NDC80 using genomic, transcriptomic, and proteomic data from 33 cancer types in The Cancer Genome Atlas, Clinical Proteomic Tumor Analysis Consortium, Genotype-Tissue Expression, and Human Protein Atlas. Results The results demonstrated frequent NDC80 mutations across multiple malignancies and significantly elevated expression in tumor tissues compared with that in their normal counterparts, correlating with worse overall and disease-free survival. Moreover, NDC80 expression was strongly associated with oncogenic pathways, key protein regulators, cellular components, myeloid-derived suppressor cell infiltration, ESTIMATE scores, and cancer-related signaling networks. Conclusions These findings underscore the potential of NDC80 as a prognostic biomarker and therapeutic target for cancer treatment.